GYRE THERAPEUTICS, INC. — Director's Dealing 2023

Nov 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GYRE THERAPEUTICS, INC. (GYRE)
CIK: 0001124105
Period of Report: 2023-10-31

Reporting Person: Parry Renate (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-31	Stock Option (Right to Buy)	$6.93	A	1866	Acquired	2033-10-31	Common Stock (1866)	Direct

Footnotes

F1: These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.